GABRA5

GABRA5 encodes the α5 subunit of GABAA receptors, which assembles into α5β3γ2 pentameric ligand-gated chloride channels that mediate tonic GABAergic inhibition in the brain and regulate neuronal excitability, metabolic homeostasis, and adipose tissue thermogenesis. Disease-associated missense mutations in transmembrane domains (e.g., p.V294L, p.V294F, p.S413F) alter GABA sensitivity, receptor desensitization, endoplasmic reticulum processing, cell-surface trafficking, and synaptic clustering, establishing both gain- and loss-of-function mechanisms contributing to early-onset epilepsy (PMID:29961870, PMID:31056671). Genetic ablation of Gabra5 in mice triggers homeostatic compensation including a ~40% reduction in HCN1-mediated Ih current in hippocampal neurons, demonstrating co-regulation between tonic GABAergic and hyperpolarization-activated cation conductances (PMID:23516534). In the lateral hypothalamic area, GABRA5-positive neurons polysynaptically innervate adipose tissue to control thermogenesis and body weight, and are tonically inhibited by astrocyte-derived GABA synthesized via monoamine oxidase B during diet-induced obesity (PMID:37653043).

1. 1997 Medium

   Establishing the genomic architecture of GABRA5 — its 11-exon structure, chromosomal location at 15q11-q13, proximity to GABRG3, and three alternative 5′ UTR isoforms driven by distinct promoters — provided the foundational gene model and explained tissue- and brain-region-specific transcriptional regulation.

   Evidence Genomic contig construction, exon mapping, FISH, 5′ RACE, Northern blot, and CAT reporter assays in human brain and transfected cells

   PMID:7601451 PMID:9126483 PMID:9205108

   Open questions at the time

   • Which transcription factors drive the three alternative promoters remains undefined
   • Protein-level confirmation of isoform-specific expression in brain subregions was not performed
2. 2013 High

   Demonstrating that Gabra5 knockout mice exhibit compensatory downregulation of HCN1 and reduced Ih in hippocampal neurons established that α5-containing GABAA receptors and HCN channels are homeostatically co-regulated, revealing a mechanism by which tonic inhibition is coupled to intrinsic neuronal excitability.

   Evidence Whole-cell patch-clamp recordings from cultured embryonic and ex vivo CA1 hippocampal neurons of Gabra5−/− mice; Western blot for HCN1 protein

   PMID:23516534

   Open questions at the time

   • The signaling pathway linking loss of α5-mediated tonic inhibition to HCN1 downregulation is unknown
   • Whether this co-regulation occurs in brain regions beyond hippocampus is untested
3. 2018 High

   Functional characterization of the epilepsy-associated p.V294L variant revealed a gain-of-function mechanism — increased GABA sensitivity coupled with enhanced desensitization — providing the first direct link between a specific GABRA5 mutation and altered channel gating in disease.

   Evidence Whole-cell patch-clamp recordings from HEK293T cells expressing recombinant α5β3γ2 GABAA receptors with the p.V294L substitution

   PMID:29961870

   Open questions at the time

   • In vivo neuronal consequences of V294L on network excitability were not tested
   • Whether enhanced desensitization leads to net loss or gain of tonic inhibition in intact circuits is unresolved
4. 2019 High

   Characterization of additional epilepsy-associated variants (p.V294F, p.S413F) showed that transmembrane domain mutations can impair receptor biogenesis at the ER level, reduce surface expression and synaptic clustering, and decrease GABA potency, establishing loss-of-function as a second disease mechanism complementary to the gain-of-function V294L.

   Evidence Whole-cell patch-clamp electrophysiology, immunofluorescence clustering assays, and biochemical ER processing analysis in neuronal and non-neuronal cells

   PMID:31056671

   Open questions at the time

   • Structural basis for differential effects of V294L versus V294F on gating versus trafficking is not resolved
   • Patient-derived neuronal models have not been used to validate these findings
5. 2022 Medium

   POMC neuron-specific knockdown of Gabra5 increased firing rate and improved glucose tolerance in male but not female mice, revealing a sexually dimorphic metabolic role for α5-mediated inhibition in hypothalamic energy-sensing circuits.

   Evidence CRISPR-Cas9-mediated POMC-specific knockdown; patch-clamp electrophysiology of POMC neurons; glucose tolerance tests in both sexes

   PMID:36120438

   Open questions at the time

   • Single study; independent replication is needed
   • Molecular basis of sex-specific effects is unexplored
   • Whether this reflects α5-specific tonic inhibition versus compensation by other subunits is unclear
6. 2023 High

   Identification of GABRA5-positive lateral hypothalamic neurons that polysynaptically control adipose thermogenesis — and are tonically silenced by astrocyte-derived GABA via MAO-B in obesity — established a brain-to-fat circuit through which α5-containing receptors regulate whole-body energy expenditure.

   Evidence Chemogenetic (DREADD) manipulation, anterograde/retrograde neural tracing, AAV-shRNA gene silencing, in vivo electrophysiology, and MAO-B pharmacological inhibition in mice

   PMID:37653043

   Open questions at the time

   • Whether this circuit is conserved in humans is unknown
   • The specific GABAA receptor subunit composition on these LHA neurons beyond α5 has not been defined
   • Downstream signaling from LHA GABRA5 neurons to adipose sympathetic outflow is not fully mapped

• Key unresolved questions include the structural basis for how different transmembrane domain mutations produce opposite functional outcomes (gain- versus loss-of-function), whether the α5/HCN1 homeostatic axis operates through a defined signaling intermediate, and how the metabolic functions of GABRA5 in hypothalamic circuits integrate with its well-characterized role in hippocampal tonic inhibition.
• No high-resolution structure of α5-containing GABAA receptors with disease mutations
• Signaling pathway linking α5-mediated tonic inhibition to HCN1 expression is undefined
• Human relevance of LHA and POMC neuron GABRA5 metabolic circuits is untested